Equitable Trust’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$413K Hold
860
0.02% 360
2025
Q4
$483K Hold
860
0.02% 321
2025
Q3
$442K Hold
860
0.02% 335
2025
Q2
$270K Sell
860
-2,033
-70% -$610K 0.01% 396
2025
Q1
$881K Buy
2,893
+580
+25% +$195K 0.05% 237
2024
Q4
$768K Sell
2,313
-444
-16% -$151K 0.04% 258
2024
Q3
$920K Buy
2,757
+444
+19% +$169K 0.06% 217
2024
Q2
$953K Buy
2,313
+303
+15% +$120K 0.07% 204
2024
Q1
$812K Hold
2,010
0.06% 229
2023
Q4
$616K Buy
2,010
+1,150
+134% +$310K 0.05% 242
2023
Q3
$208K Hold
860
0.02% 387
2023
Q2
$207K Buy
+860
New +$179K 0.02% 389
2022
Q1
Sell
-1,491
Closed -$325K 406
2021
Q4
$325K Hold
1,491
0.02% 307
2021
Q3
$282K Hold
1,491
0.02% 318
2021
Q2
$263K Hold
1,491
0.02% 320
2021
Q1
$245K Sell
1,491
-885
-37% -$135K 0.02% 320
2020
Q4
$331K Buy
2,376
+235
+11% +$29.6K 0.02% 283
2020
Q3
$239K Buy
+2,141
New +$248K 0.02% 292

Other funds holding MEDP

Equitable Trust's MEDP Position: Q1 2026 in Review

Equitable Trust held its Medpace (MEDP) position steady in Q1 2026 at 860 shares worth $413K. The position accounts for 0.02% of the portfolio, ranked #360.

Equitable Trust first reported a position in MEDP in Q3 2020 and has held it in 18 quarters since. The position peaked at $953K in Q2 2024. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Equitable Trust held 860 shares of Medpace worth $413K as of Q1 2026.
  • Equitable Trust left its Medpace share count unchanged in Q1 2026.
  • Medpace made up 0.02% of Equitable Trust's portfolio in Q1 2026, its #360 holding.
  • Equitable Trust first reported a position in Medpace in Q3 2020 and has held it in 18 quarters since.
  • Equitable Trust's Medpace position peaked at $953K in Q2 2024.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Equitable Trust's 13F filing for Q1 2026, filed 30 Apr 2026.